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Abstract
Background:  Multi-detector computed tomography angiography (MDCTA)of the coronary
arteries after stenting has been evaluated in multiple studies.
The purpose of this study was to perform a structured review and meta-analysis of the diagnostic
performance of MDCTA for the detection of in-stent restenosis in the coronary arteries.
Methods: A Pubmed and manual search of the literature on in-stent restenosis (ISR) detected on
MDCTA compared with conventional coronary angiography (CA) was performed. Bivariate
summary receiver operating curve (SROC) analysis, with calculation of summary estimates was
done on a stent and patient basis. In addition, the influence of study characteristics on diagnostic
performance and number of non-assessable segments (NAP) was investigated with logistic meta-
regression.
Results: Fourteen studies were included. On a stent basis, Pooled sensitivity and specificity were
0.82(0.72–0.89) and 0.91 (0.83–0.96). Pooled negative likelihood ratio and positive likelihood ratio
were 0.20 (0.13–0.32) and 9.34 (4.68–18.62) respectively. The exclusion of non-assessable stents
and the strut thickness of the stents had an influence on the diagnostic performance. The
proportion of non-assessable stents was influenced by the number of detectors, stent diameter,
strut thickness and the use of an edge-enhancing kernel.
Conclusion: The sensitivity of MDTCA for the detection of in-stent stenosis is insufficient to use
this test to select patients for further invasive testing as with this strategy around 20% of the
patients with in-stent stenosis would be missed. Further improvement of scanner technology is
needed before it can be recommended as a triage instrument in practice. In addition, the number
of non-assessable stents is also high.
Background
Coronary artery disease (CAD) remains one of the leading
causes of death and morbidity in the Western world. Each
year one million patients are treated percutaneously with
stent implantation [1]. Unfortunately angioplasty and
stent implantation is not a permanently curative treat-
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ment and even with drug eluting stents, a substantial frac-
tion of patients will develop recurrent symptoms due to
in-stent restenosis (ISR). Cumulative frequency of steno-
sis immediately after stenting and at six months in
patients who received sirolimus-eluting stents and stand-
ard stents showed the following pattern: at six months,
restenosis, defined as luminal narrowing of 50 percent or
more occurred in no patient with a sirolimus stent com-
pared to 23 percent of those with standard stents. The per-
centage of stenosis at six months with sirolimus stents was
essentially the same as that immediately after the proce-
dure and in all cases was less than 35 percent [2]. In a
recent meta-analysis, restenosis was also highly reduced
from 31.7% with bare stents to 10.5% with DES [3].
Invasive coronary angiography (CA) is the standard of ref-
erence for the evaluation of stent patency and the exclu-
sion of in-stent restenosis (ISR). Although it has a small
risk of complications it is an invasive procedure with sig-
nificant costs [4-6]. A non-invasive technique for the
assessment of stent patency would therefore be highly
desirable.
Multi-detector computed tomography angiography
(MDCTA) of the coronary tree has been evaluated in mul-
tiple studies, to assess the patency of the lumen after stent
implantation [7-20]. All studies use different scanning
protocols and scanner types, and the reported figures for
diagnostic accuracy for ISR exhibit considerable variabil-
ity. Also, a multitude of stent types and stent sizes exist
and have been evaluated with MDCTA, with varying
results for diagnostic accuracy. It has been shown in mul-
tiple studies in vitro and in vivo that 4 detector MDCTA is
not reliable for evaluation of ISR [21,22]. However 16 and
64 detector MDCTA showed a higher potential. The pur-
pose of this study was to evaluate the pooled diagnostic
accuracy of MDCTA with 16 detectors or higher for the
detection of in-stent restenosis and to determine the influ-
ence of study characteristics on the diagnostic perform-
ance of MDCTA.
We tried to frame the question starting from the potential
future use of MDCTA in evaluation of stent patency. A
potential use that is probably reasonable is using MDCTA
as a triage modality on the result of which a decision can
be made whether the patient needs invasive angiography
[23]. This calls for a test with a high sensitivity on a patient
and stent basis, to minimize the amount of false negative
patients, that are otherwise denied correct diagnosis and
therapy.
Methods
Study selection
To search for original articles, a structured search of the
PUBMED database from January 1998 to March 2007 was
performed using the previously described PICO search
strategy [24], by three authors (PV, OB, ID). The acronym
stands for: "P" = patient or group of patients, "I" = inter-
vention, "C" = comparison intervention, and "O" = out-
come. The use of the PICO strategy in the PUBMED
database provides a conceptual framework for more effec-
tive searching. Entering medical subject heading (MeSH)
terms in each concept of the PICO question resulted in a
reference list of articles on a given topic. Although the
exclusive use of MeSH terms has been described to have
limitations, and other strategies or combinations have
been advocated we confined ourselves to this method
[25]. For this study the following MeSH terms were
entered: P: coronary restenosis; I: tomography, spiral com-
puted; C: coronary angiography; O: diagnosis. The result-
ing reference lists of review articles and cited articles was
used to locate potential additional studies. Studies were
included in the meta-analysis if they met the following
inclusion criteria: patients both underwent coronary ang-
iography (CA) and MDCTA as a follow up after stent
implantation; the data were acquired with a multi-detec-
tor CT-scanner with at least 16 detectors; CA was used as
the reference standard in all patients; the absolute num-
bers of true-positive, true-negative, false-positive and
false-negative are possible to extract from the article; these
absolute numbers were accepted if they were derived on a
per stent basis. Exclusion criteria were: inability to obtain
original numbers of false-positives (FP), false-negatives
(FN), true-positives (TP), and true-negatives (TN); review
article or a comment to the editor; studies not published
in English; case reports; in vitro or phantom studies, and
miscellaneous (Table 1). Three independent readers (PV,
OB, ID) each independently evaluated the retrieved stud-
ies for possible inclusion as follows: Each investigator
independently evaluated the retrieved studies for possible
inclusion. In the case of conflicting findings as to whether
a paper should be included, a decision was reached by
consensus. In a first round articles were eliminated that
clearly did not match the inclusion criteria, on the basis of
the title or the abstract. In a second round, hard copies of
the papers that gave rise to doubt on the basis of their
abstracts were obtained and the full text was read, again
eliminating a group of papers. The final group consisted
of the included papers. Although quality scores have been
criticized [26] we choose to guide the inclusion of studies
as final gatekeeper by the quality of the study design and
reporting. Formal quality assessment, Quality Assessment
of Diagnostic Accuracy Studies (QUADAS, 27) was per-
formed (third round, fig 1f). A maximum of 14 points was
used to judge the quality in the final evaluation of
included articles, and a score of ≥ 12 was considered
acceptable.
Data extraction
The study parameters were extracted first independently
and subsequently by consensus if a disagreement existed
between the observers concerning the numeric value of aBMC Medical Imaging 2008, 8:14 http://www.biomedcentral.com/1471-2342/8/14
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parameter (PV, OB, ID). The absolute numbers of FN, FP,
TP, TN were retrieved or calculated. The numbers were cal-
culated with Bayes theorem if only values for sensitivity,
specificity, and predictive values were reported. This was
done on a per stent basis and per patient basis.
MDCTA was considered true-positive per stent if an in-
stent restenosis (≥ 50% diameter stenosis) was found on
MDCTA and confirmed on CA. MDCTA was considered
true-negative if in-stent restenosis was correctly ruled out.
MDCTA was considered false-negative if no in-stent reste-
nosis was found on MDCTA and one was found on CA.
MDCTA was considered false-positive if it revealed an in-
stent restenosis and CA showed no in-stent restenosis. For
the per patient analysis a patient was classified in one of
these categories according to the authors decision.
Data synthesis and statistical analysis
All values are expressed as mean value with 95% confi-
dence intervals (95%CI) unless otherwise specified.
Interobserver agreement for study selection was evaluated
with Cohen's Kappa test in which a value higher than 0.8
is considered to imply very good to excellent agreement.
The different rounds of study selection were evaluated.
The analysis was performed on a per stent basis, as most
studies focused on this level of information. We also did
a evaluation on a per patient basis.
We evaluated potential heterogeneity and inconsistency
between publications expressed with the Higgins and
Thompson index [28] which calculates the I2 statistic, and
is a derivative of Cochran's Q [29,30]. Cochran's Q dis-
plays a low power for detection of inconsistency when the
number of studies is low, and a too high power when the
number of studies is high. A value of 0% indicates no
observed heterogeneity, and values greater than 50% may
be considered substantial heterogeneity.
Publication bias was assessed according to the method
introduced by Deeks [31]. This method uses a slightly dif-
ferent approach, than the more classic methods [32,33]
and is an optimized method suited for studies of diagnos-
Table 1: Quadas table.
1234567891 0 1 1 1 2 1 3 1 4
Schuijf 7 YY YYYYYYYY Y Y Y Y
Cademartiri 8 YU YYYYYYYY Y Y U U
Gilard 9 YY YYYYYYYY Y Y U U
Gaspar 10 YU YYYYYYYY Y Y Y U
Chabbert 11 YY YYYYYYYY Y Y Y Y
Gilard 12 YY YYYYYYYY Y Y Y Y
Ohnuki 13 YNYYYYYYYY Y Y Y Y
Watanabe 14 YNYYYYYYYY Y Y Y Y
Van Mieghem 15 YY YYYYYYYY Y Y Y Y
Rist 16 YY YYYYYYYY Y Y Y Y
Rixe 17 YY YYYYYYYY Y Y Y Y
Kefer 18 YY YYYYYYYY Y Y Y Y
Ehara 19 YY YYYYYYYY Y Y Y Y
Oncel 20 YY YYYYYYYY Y Y Y Y
For meaning of items, see [27]
Flow chart for the search strategy used Figure 1
Flow chart for the search strategy used. Out of 485 
articles found with the PICO search strategy 11 articles were 
included. Together with the cross reference search in total 
14 articles were included.BMC Medical Imaging 2008, 8:14 http://www.biomedcentral.com/1471-2342/8/14
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tic accuracy. A regression line for graphic analysis of pub-
lication bias is constructed. This plot is a regression of
each study's effect size against some measure of its size,
such as the 1/root(effective sample size), used here. The
existence of publication bias can be expressed as the slope
and intercept of a linear regression line between study size
and effect. If the slope is not statistically different from
zero, there is no publication bias.
We performed a summary receiver characteristic operating
curve (SROC) analysis tailored to meta-analysis of diag-
nostic accuracy that takes into account any possible corre-
lation between sensitivity and specificity in addition to
within-study variation (precision) and between study var-
iation (random effects approach). We used the bivariate
meta regression approach since recent work has shown
that the standard approach [34,35] can perform poorly
when calculating p-values and confidence intervals [36].
Logistic meta-regression was performed with the same
bivariate SROC model to evaluate the influence of several
covariables on diagnostic accuracy and to identify possi-
ble causes for heterogeneity in sensitivity and specificity.
The evaluated covariables included: Exclusion versus
inclusion of non assessable stents expressed as a dichoto-
mous value (yes/no), the time interval between CA and
MDCT examination (number of months), brand of the
scanner and the number of detectors used, the use of an
edge-enhancing kernel or algorithm (soft, hard or a com-
bination of the two), Tube voltage in Kv, strut thickness
expressed as a dichotomous value (< 100 μm, ≥ 100 μm),
the localization of the stent (in the left main, in all other
coronary vessels) and mean diameter of stents used. The
type of stent (bare metal, drug eluting) or brand of stent
was not evaluated because it was impossible to homoge-
nize the data, due to the extreme variability in the stents
that were used. Tube current was not investigated either
because the method of reporting varied widely. Other
scan parameters were not investigated because they were
reported not to have an influence in a previous meta-anal-
ysis [37]. The method of collecting and describing the data
is summarized in Table 2. First, a screening for subgroups
or strata defined by the covariables was done. Thereafter,
some selected covariables were further investigated,
depending on the presence of enough data per subgroup
(at least three studies per stratum, required by our soft-
ware). We focused on calculation of summary estimates of
sensitivity (SE) and specificity (SP) and used likelihood
ratio's for illustration of the diagnostic performance in the
target group and their inherent prevalence of ISR (approx
20%). Forest plots were generated for SE and SP, and con-
ditional likelihood graphs for likelihood ratio's and SROC
curve with elliptical display of confidence intervals and
prediction region. The decision not to focus on diagnostic
odds ratio's was taken on the basis of the fact that we were
interested in the sensitivity and specificity of the tech-
nique. Likelihood ratio's were calculated on the basis of
the pooled estimates of SE and SP obtained with the bivar-
iate SROC model [38]. The proportion of non assessable
stents (NAP), defined as the ratio of non-assessable stents
per number of evaluated stents was also pooled with a
Table 2: Covariables for logistic (meta-)regression.
Author Ndet brand Kernel CT/PCI NAP StrTh EXC location size Age Kv
Schuijf 7 1 4 0 14 0.23 1 0 2 - 62 120
Cademartiri 8 1 1 0 6 0.02 0 1 2 - 60 120
Gilard 9 1 3 0 6 0.07 0 1 1 3.9 63 120
Gaspar 10 2 3 0 0 0.05 2 0 2 3.3 63 120
Chabbert 11 1 1 4 6 0.26 0 0 2 3.25 67.4 120
Gilard 12 1 3 0 12 0.46 0 1 2 3.13 68 120
Ohnuki 13 1 1 2 0 0.00 0 0 2 3.32 65 120
Watanabe 14 1 1 1 6 0.17 0 1 2 3.3 64 120
Van Mieghem 15 3 1 2 8 0.09 0 1 1 3 61 120
Rist 16 4 1 4 1 0.02 2 1 2 3.16 59 120
Rixe 17 4 1 2 13 0.42 2 0 2 2.97 58 120
Kefer 18 1 3 2 12 0.07 0 1 2 2.8 64 140
Ehara 19 4 1 2 3 0.00 1 0 2 3.27 67 120
Oncel 20 4 1 2 20.1 0.00 0 0 2 3.17 58.2 120
Ndet: number of detectors. 1 = 16, 2 = 40, 3 = 16/64, 4 = 64
Brand: 1 = Siemens, 2 = GE, 3 = Philips, 4 = Toshiba
Kernel: 1 = B20-30f, 2 = B46f, 3 = B46, f + filter, 4 = combination
CT/PCI: average number of months between scan and stent placement
NAP: Non-assessable proportion of stents
StrTh: Strut Thickness. 0 = no data, 1 = Str Th < 100 μm, 2 = Str Th > 100 μm
EXC: non-assessable stents were excluded before analysis: 1, not excluded: 0
Loc: Stent location in the coronary. Left main or not specified = 1, other = 2
Size: average stent diameter in mm
Kv: kilovoltageBMC Medical Imaging 2008, 8:14 http://www.biomedcentral.com/1471-2342/8/14
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random effects model for meta-analysis of proportions,
and a logistic meta-regression on NAP was performed
with the same covariables except for one: exclusion versus
inclusion of non assessable stents. All calculations were
performed with STATA. (Version 10, Special Edition,
StataCorp, 4905 Lakeway Drive, College Station, Texas
77845 USA.)
Results
Study selection and data extraction
The PUBMED search for original articles resulted in 485
articles. 449 articles were excluded on the basis of their
title or abstract with 36 remaining for further evaluation.
From these 36 articles, 11 were finally included in the
meta-analysis [7,10-12,14-20]. Three additional articles
found on the basis of cross references were also finally
included in the meta-analysis [8,9,13]. No studies were
excluded on the basis of QUADAS when considering this
final group. QUADAS was scored with yes, no or unclear
for the criterium investigated and a table was constructed
(Table 1).
The final group of studies consisted of 4 studies on 64-
detector CT, 1 on 40-detector CT, 1 on a combination of
64- and 16-detector CT, and 8 on 16-detector CT. 24 stud-
ies were excluded. Number and reasons for exclusion are
found in Table 1. A Flow diagram of the review process is
given in figure 1. In additional file 1 the studies that were
excluded were cited and classified according to Table 3.
Interobserver agreement (Cohen's Kappa) for the selec-
tion of articles between the three readers was respectively
0.75, 0.87 and 1.0 for the different search rounds.
Important study characteristics are displayed in Table 2.
Data synthesis and statistical analysis
A total of 1039 stents were analyzed. In the per patient
analysis 400 patients were analysed.
Raw data from the included studies are displayed in Table
4 (per stent analysis) an 5 (per patient analysis).
Substantial inconsistency between studies was found
when calculating the pooled SE and SP on a stent basis
with the bivariate model (I2, 91.42%, 79.51%, respec-
tively).
There was no substantial publication bias: Per stent: Slope
4.62 (p, 0.67), Intercept 3.10 (p, 0.09 Per patient: slope
3.62 (p, 0.81), Intercept 2.96 (p, 0.24)
The pooled values for detecting significant ISR on a stent
basis were as follows: Pooled sensitivity and specificity
were 0.82 (0.72–0.89) and 0.91 (0.83–0.96). Pooled neg-
ative likelihood ratio and positive likelihood ratio were
0.20 (0.13–0.32) and 9.34 (4.68–18.62) respectively. Val-
ues on a patient basis are found in figures 2 and 3.
Forest plots for pooled sensitivity, specificity, are graphed
in figures 2, 3, 4 and 5.
Random effects SROC curve and conditional probability
plots are displayed in figure 6, 7, 8 and 9. The results of
meta-regression are outlined in Table 6. Using a threshold
of p < 0.05 for statistical significance, none of the evalu-
ated covariables were significant predictors of sensitivity.
The only significant predictor of specificity was the exclu-
sion of non-assessable segments (p 0.003). A few selected
covariables that were amenable to meaningful subgroup
analysis are displayed with their stratum specific sensitiv-
ities and specificities in Table 7. Logistic metaregression
on a per patient basis showed no predicting covariables.
The pooled NAP was 0.11 (95%CI, 0,04–0,20, range
0.00–0.46). Meta-regression on NAP showed that it was
influenced by the number of detectors, stent diameter,
strut thickness and the use of an edge-enhancing kernel
(Table 8).
Discussion
The results of this study showed that pooled sensitivity
and specificity on a stent basis were 0.82 (0.72–0.89) and
0.91 (0.83–0.96) which is moderate (sensitivity) to very
good (specificity). Considerable inconsistency/heteroge-
neity was found between all included studies. There was
no difference in the diagnostic performance between
scanners with 16 or 64 detectors and the only variable that
showed to have influence on diagnostic performance was
the exclusion of non-assessable stents before analysis. The
proportion of stents that was non assessable showed a
very important variability, and was in one study as high as
0.46 and showed a pooled value of 0.11. Meta-regression
on NAP showed that it was influenced by the number of
detectors, stent diameter, strut thickness and the use of an
edge-enhancing kernel. This is probably reflecting evolv-
Table 3: Numbers and reasons for exclusion
Reason for exclusion
Case Report 9
Comment to the editor 1
No English 3
Review Article 2
In Vitro/Phantom studies 2
Unability to obtain FN, FP, TN, TP 6
Miscellaneous 2
Total 25
FN: False Negative
FP: False Positive
TN: True Negative
TP: True PositiveBMC Medical Imaging 2008, 8:14 http://www.biomedcentral.com/1471-2342/8/14
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ing stent technology, as will be stated later in this discus-
sion
Pooled negative likelihood ratio and positive likelihood
ratio were 0.20 (0.13–0.32) and 9.34 (4.68–18.62)
respectively. For a test to be helpful in diagnosis, it is gen-
erally accepted that LR+ should be higher than 10 and LR-
below 0.1 [39].
These results underscore the fact that demonstration of
ISR with MDCTA can be done but still suffers from some
problems, and that non-invasive imaging of stents to rule
out ISR (moderate sensitivity) remains a challenge, even
after the addition of 16 to 64 detector MDCTA to the diag-
nostic armentarium. The sensitivity is probably not good
enough to use the technique as a rule-out triage modality.
Table 4: Raw data on a stent basis.
Author Journal Year FP TP TN FN SE (95%CI) SP (95%CI)
Schuijf 7 Am J Card 2004 15 7 41 2 0.78 0.40 0.73 0.60
0.97 0.84
Cademartiri 8 Am J Card 2005 1 5 67 1 0.83 0.36 0.99 0.92
1.00 1.00
Gilard 9 Am J Card 2005 2 2 25 0 1.00 0.16 0.93 0.76
1.00 0.99
Gaspar 10 JACC 2005 11 14 78 8 0.64 0.41 0.88 0.79
0.83 0.94
Chabbert 11 Eur Rad 2006 28 21 57 2 0.91 0.72 0.67 0.56
0.99 0.77
Gilard 12 Heart 2006 0 10 108 4 0.71 0.42 1.00 0.97
0.92 1.00
Ohnuki 13 Int J card 2006 2 3 14 1 0.75 0.19 0.88 0.62
0.99 0.98
Watanabe 14 circulation 2006 2 6 27 0 1.00 0.54 0.93 0.77
1.00 0.99
Van Mieghem 15 circulation 2006 5 10 55 0 1.00 0.69 0.92 0.82
1.00 0.97
Rist 16 Acad Radiol 2006 3 6 34 2 0.75 0.35 0.92 0.78
0.97 0.98
Rixe 17 Eur Heart Jnl 2006 39 6 51 6 0.50 0.21 0.57 0.46
0.79 0.67
Kefer 18 Eur Rad 2007 1 12 50 6 0.67 0.41 0.98 0.90
0.87 1.00
Ehara 19 JACC 2007 19 22 82 2 0.92 0.73 0.81 0.72
0.99 0.88
Oncel 20 Radiology 2007 1 17 19 2 0.89 0.67 0.95 0.75
0.99 1.00
FP: False positive
TP: True positive
TN: True negative
FN: False negative
CI: Confidence intervals
Table 5: Raw data on a patient basis.
Author FP TP TN FN SE (95%CI) SP(95%CI)
Schuijf 7 15 7 41 2 0.77 0.400 – 0.97 0.73 0.59 – 0.84
Gilard 9 2 2 25 0 1.00 0.15 – 1.00 0.92 0.75 – 0.99
Gaspar 10 11 14 78 8 0.63 0.40 – 0.82 0.87 0.79 – 0.93
Van Mieghem 15 5 10 55 0 1.00 0.69 – 1.00 0.91 0.81 – 0.97
Ehara 19 19 22 82 2 0.91 0.73 – 0.99 0.81 0.72 – 0.88
FP: False positive
TP: True positive
TN: True negative
FN: False negative
CI: Confidence intervalsBMC Medical Imaging 2008, 8:14 http://www.biomedcentral.com/1471-2342/8/14
Page 7 of 11
(page number not for citation purposes)
On the basis of studies in vitro, a logical and intuitively
attractive concept has been formulated on stent imaging
with MDCTA [21,22]. Thick struts, stent size and stent
material were found to have an influence on the capability
of MDCTA to visualize the stent lumen. Smaller stents,
thicker struts and dense stent material (bare metal) were
more difficult to image without beam-hardening artefacts
and blooming. This concept (except for stent material)
could be confirmed by the pooled analysis in this study.
The influence was not directly on diagnostic performance
but through the number of non assessable segments, that
was higher in stents with a smaller diameter and thicker
struts. One possible explanation that the possible effect of
stent material could not be confirmed is that it was diffi-
cult to identify groups of identical stents which resulted in
a statistical lack of power.
In addition to these stent related factors, scan acquisition
parameters (number of detectors and the use of an edge
enhancing kernel) had an influence, also through the
number of non-assessable segments.
Although these principles suggest that stent imaging with
MDCTA is not always straightforward and prone to failure
in certain stents, the general trend in interventional cardi-
ology to use stents with thinner struts and less dense mate-
rial will probably obviate at least some of this problem.
Also scanner technology is advancing quickly and some of
the scanner related problems will probably also be obvi-
ated in the future.
As said previously, non-invasive evaluation of coronary
artery disease after stent placement is a clinical challenge,
and CA is not recommended as a routine follow-up tech-
nique due to the associated risks and cost. Therefore, non-
Forest plot for pooled sensitivity per stent Figure 2
Forest plot for pooled sensitivity per stent.
Forest plot for pooled sensitivity per patient Figure 3
Forest plot for pooled sensitivity per patient.
Forest plot for pooled specificity per stent Figure 4
Forest plot for pooled specificity per stent.
Forest plot for pooled specificity per patient Figure 5
Forest plot for pooled specificity per patient.BMC Medical Imaging 2008, 8:14 http://www.biomedcentral.com/1471-2342/8/14
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invasive follow-up of ISR and re-occurrence of myocardial
ischemia has been investigated with a variety of tech-
niques. ECG stress testing has been tested and in a recent
overview, sensitivity and specificity was 54% and 70%
respectively, which is clearly insufficient for a triage
modality [40]. Myocardial perfusion imaging with
nuclear techniques and with contrast echocardiography
has been documented previously [41,42]. Sensitivity and
Specificity for the diagnosis of regional restenosis was
73% and 75% respectively in the contrast echo study and
76% and 83% in the 99 m technetium tetrofosmin myo-
cardial perfusion imaging, values which are inferior to
MDCTA on a per stent basis and almost equal on per
patient basis, but both worse for specificity on a stent an
patient basis than the pooled diagnostic performance
with MDCTA. MRI has also been tested for this purpose,
but imaging of stents remains only possible in certain
stents, no formal data on diagnostic performance have
been published and experience remains largely anecdoti-
cal [43-45].
We have to acknowledge some limitations in this study.
The rather small size of the individual cohorts and the
methodology (examining very different stents and stent
sizes in each study) resulted in a heterogenous group of
stents that make it cumbersome to reliably pool the data.
This makes it also harder to obtain reliable results with the
technique of multivariable logistic meta-regression, due
SROC from the bivariate model for pooled data per stent Figure 6
SROC from the bivariate model for pooled data per 
stent. SENS: sensitivity, SPEC: Specificity, AUC: Area under 
the curve.
SROC from the bivariate model for pooled data per patient Figure 7
SROC from the bivariate model for pooled data per 
patient. SENS: sensitivity, SPEC: Specificity, AUC: Area 
under the curve.
Conditional Probability plots per stent Figure 8
Conditional Probability plots per stent. LR+: positive 
likelihood ratio, LR-: negative likelihood ratio.
Conditional Probability plots per patient Figure 9
Conditional Probability plots per patient. LR+: positive 
likelihood ratio, LR-: negative likelihood ratio.BMC Medical Imaging 2008, 8:14 http://www.biomedcentral.com/1471-2342/8/14
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to the very high number of explanatory variables (differ-
ent stents) involved.
Some clear disadvantages of MDCTA are the relatively
high radiation dose that goes with the examination, with
average doses ranging from 10 to 20 mS [46], and the
influence of an irregular rhythm [47,48] on the diagnostic
performance of MDCTA.
Since MDCTA technology and stent technology is advanc-
ing very rapidly, future studies should focus on the use of
state-of the art equipment both in terms of scan method-
ology and in terms of the stents investigated. If ISR is stud-
ied in patients, rigorous methodology to group enough
stents of the same size and type should be done, prefera-
bly in larger and important anatomical locations. This
would probably be very helpful to predict which patients
and stents are good candidates to be investigated with
MDCTA, with a reasonable change of obtaining images
that can be reliably interpreted.
Pooled analysis of diagnostic performance of MDCTA of
ISR shows that the technique is probably useful, but that
more thorough and uniform investigation of modern
stents with the latest equipment will probably be needed
to shed more light on the clinical usefulness of this tech-
nique. The diagnostic performance is influenced by the
method of reporting (exclusion of non-assessable stents).
The proportion of non-assessable stents is influenced by
the number of detectors, stent diameter, strut thickness
and the use of an edge-enhancing kernel.
Table 6: Results for the bivariate logistic meta-regression on diagnostic performance: per stent analysis and detection of subgroups.
Covariable Sensitivity (95%CI) p value Specificity (95%CI) p value
Year of publication 0.84 [0.71–0.92] 0.64 0.93 [0.81–0.98] 0.72
No of detectors 0.82 [0.70–0.89] 0.97 0.88 [0.76–0.95] 0.57
Brand 0.74 [0.62–0.84] 0.29 0.93 [0.83–0.97] 0.74
Kernel 0.84 [0.73–0.90] 0.65 0.88 [0.76–0.94] 0.52
CTPCI 0.80 [0.69–0.88] 0.91 0.91 [0.82–0.96] 0.99
Strth 0.78 [0.69–0.85] 0.14 0.89 [0.79–0.94] 0.16
Exc 0.83 [0.67–0.93] 0.72 0.97 [0.93–0.98] 0.00
Location 0.00 [0.00–1.00] 1.00 0.89 [0.46–0.99] 0.82
Size 0.98 [0.62–1.00] 0.19 0.88 [0.24–0.99] 0.86
Age 0.79 [0.68–0.87] 0.84 0.93 [0.86–0.97] 0.74
Kv 0.81 [0.72–0.88] 0.91 0.92 [0.85–0.96] 0.85
If p-value is below 0.05 significant subgroups exist attributable to the investigated covariable. Sensitivity and specificity is given for the most deviating 
stratum with p-value comparing the values with the complete group without stratification. Only one covariable results in significant difference 
between strata: specificity is significantly different when grouping studies that excluded or included non-assessable segments. See also table 6 that 
compares some stratum specific sensitivities and specificities.
Legend for covariables see table 3
95% CI: 95% Confidence intervals
Table 7: Results of bivariate analysis with covariables, per stent analysis.
Study characteristic No of studies sensitivity 95% CI specificity 95% CI
All studies 14 0.82 0.72–0.89 0.91 0.83–0.96
Number of detectors
64 4 0.83 0.71–0.90 0.89 0.70–0.97
lower 10 0.81 0.68–0.89 0.93 0.85–0.97
Non assessable excluded
yes 7 0.84 0.66–0.93 0.97 0.93–0.99
no 7 0.81 0.66–0.90 0.79 0.68–0.87
Year of publication
2004 or earlier 4 0.73 0.55–0.85 0.91 0.77–0.97
later than 2004 10 0.84 0.72–0.91 0.91 0.80–0.97
Time between MDCTA and PCI
less than 6 months 8 0.83 0.69–0.92 0.89 0.81–0.92
6 months or longer 5 0.72 0.56–0.84 0.93 0.67–0.99
Brand
Siemens 9 0.69 0.57–0.79 0.95 0.80–0.99
Philips or Toshiba 5 0.88 0.76–0.94 0.88 0.77–0.94
Stratum specific sensitivities and specificities were compared for some characteristics that were amenable to meaningful analysis of subgroups 
(arbitrary value of more than 3 studies per subgroup)BMC Medical Imaging 2008, 8:14 http://www.biomedcentral.com/1471-2342/8/14
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Conclusion
The sensitivity of MDTCA for the detection of in-stent ste-
nosis is insufficient to use this test to select patients for
further invasive testing as with this strategy around 20%
of the patients with in-stent stenosis would be missed.
Further improvement of scanner technology is needed
before it can be recommended as a triage instrument in
practice. In addition, the number of non-assessable stents
is also high.
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